SCHEMBL25877344

SCHEMBL25877344

Cc1cc(CC=O)cc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.52
CYP2A6 P11509 3/20 0.52
ALDH1A1 P00352 6/20 0.42
ERN1 O75460 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.37
TSHR P16473 2/20 0.36
TYMP P19971 1/20 0.36
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
CYP2C9 P11712 1/20 0.35
HTT P42858 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851565 0.81 CYP1A2 (0.55) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL5898006 0.81 CYP1A2 (0.55) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL11738780 0.80 CYP1A2 (0.53) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL7411772 0.79 CYP1A2 (0.42) CYP1A2CYP2A6ALDH1A1HPGDKDM4E
SCHEMBL6367430 0.79 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL7260877 0.78 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL8852070 0.78 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL11741652 0.77 NQO1 (0.43) ALDH1A1ERN1HPGDKMT2ASMN1; SMN2
SCHEMBL23465385 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G
SCHEMBL15345412 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ALDH1A1APOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234965-A1 N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 JANSSEN PHARMACEUTICA NV (BE) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234965-A1 N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 MCL1, BCL2L1, BAK1 CYP1A2 4035/4885CYP2A6 4614/4885ALDH1A1 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.